OptimizeRx Corp 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Marion Odence-ford | 1 | -4,000 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 0 | 4,000 | -4,000 |
OptimizeRx Corp 内部交易
OptimizeRx Corp 最新内部交易
Marion Odence-ford | General Counsel & CCO | 2024-01-09 | 卖出 | 4,000 | 11,114 |
$15.19
|
-30.48%
|
Marion Odence-ford | General Counsel & CCO | 2022-08-26 | 买入 | 1,000 | 5,000 |
$15.75
|
-32.95%
|
William J Febbo | CEO | 2022-08-22 | 买入 | 16,100 | 461,772 |
$15.59
|
-32.26%
|
James Paul Lang | 董事 | 2022-08-19 | 买入 | 6,000 | 38,660 |
$16.45
|
-35.81%
|
Stephen L Silvestro | CCO | 2022-08-16 | 买入 | 3,200 | 3,200 |
$15.66
|
-32.57%
|
Ellen O'connor Vos | 董事 | 2022-08-16 | 买入 | 500 | 500 |
$15.91
|
-33.63%
|
Edward Stelmakh | CFO/COO | 2022-08-15 | 买入 | 3,000 | 3,000 |
$15.43
|
-31.56%
|
William J Febbo | CHIEF EXECUTIVE OFFICER | 2022-02-18 | 卖出 | 16,666 | 445,672 |
$43.73
|
-75.85%
|
William J Febbo | CHIEF EXECUTIVE OFFICER | 2022-01-18 | 卖出 | 16,666 | 462,338 |
$47.27
|
-77.66%
|
Stephen L Silvestro | CHIEF COMMERCIAL OFFICER | 2021-12-17 | 卖出 | 13,241 | - |
$54.87
|
-80.75%
|